Anzeige
Mehr »
Dienstag, 24.03.2026 - Börsentäglich über 12.000 News
Drohnenkrieg eskaliert - und diese Aktie greift nach zwei Mega-Märkten
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
11:18B.Riley cuts Aardvark Therapeutics stock price target on trial pause
11:18BMO reiterates Intuit stock Outperform rating on tax season trends
11:18Mizuho cuts Phreesia stock price target on pharma spend concerns
11:18Daiwa upgrades JinkoSolar stock rating on Tesla patent revenue outlook
11:18Argus raises Darden Restaurants stock price target on earnings beat
11:18Argus reiterates 3M stock buy rating, sees margin improvement
11:18Argus reiterates Coinbase stock rating at Hold, cuts EPS estimates
11:18BMO upgrades Arthur J. Gallagher stock rating on AI productivity outlook
10:42Avino Q4 2025 slides: record silver revenue amid rising costs
10:42Picton Property Income confirms consortium in takeover talks
10:42Kingstone Q4 2025 slides: record profitability amid revenue challenges
10:42BofA downgrades Nordea Bank stock on stretched valuation
10:42Citizens reiterates VICI Properties stock rating on expanded development role
10:42BofA upgrades Richemont stock rating on unique growth story
10:42JMP Securities maintains Oracle stock rating on AI infrastructure strength
10:42Immunic stock initiated at Buy by Guggenheim on MS therapy potential
10:42Citizens reiterates Sutro Biopharma stock rating on pipeline progress
10:31Citizens reiterates Ocular Therapeutix stock rating amid litigation
10:31Citizens reiterates GDS Holdings stock rating on AI demand outlook
10:31Citizens reiterates Hilton Grand Vacations stock rating on model update
10:31Citizens reiterates Acrivon Therapeutics stock rating on endometrial cancer trial progress
10:31Abivax stock rating maintained at outperform by Citizens on trial data
10:31Relmada Therapeutics stock initiated at Overweight by Piper Sandler
10:31Rothschild Redburn initiates Solventum stock with Sell rating
10:31Piper Sandler initiates Generate Biomedicines stock at overweight